BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 10228024)

  • 1. Augmentation of the CD8+ T cell response by IFN-gamma in IL-12-deficient mice during Toxoplasma gondii infection.
    Ely KH; Kasper LH; Khan IA
    J Immunol; 1999 May; 162(9):5449-54. PubMed ID: 10228024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice.
    Khan IA; Kasper LH
    J Immunol; 1996 Sep; 157(5):2103-8. PubMed ID: 8757333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
    Khan IA; Casciotti L
    J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii.
    Kasper LH; Matsuura T; Khan IA
    J Immunol; 1995 Nov; 155(10):4798-804. PubMed ID: 7594482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.
    Gazzinelli RT; Hakim FT; Hieny S; Shearer GM; Sher A
    J Immunol; 1991 Jan; 146(1):286-92. PubMed ID: 1670604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells.
    Lütjen S; Soltek S; Virna S; Deckert M; Schlüter D
    Infect Immun; 2006 Oct; 74(10):5790-801. PubMed ID: 16988257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain.
    Scharton-Kersten T; Caspar P; Sher A; Denkers EY
    Exp Parasitol; 1996 Nov; 84(2):102-14. PubMed ID: 8932760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
    Khan IA; Matsuura T; Fonseka S; Kasper LH
    J Immunol; 1996 Jan; 156(2):636-43. PubMed ID: 8543815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
    Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kühn R; Müller W; Trinchieri G; Sher A
    J Immunol; 1996 Jul; 157(2):798-805. PubMed ID: 8752931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
    Hunter CA; Chizzonite R; Remington JS
    J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii.
    Buzoni-Gatel D; Lepage AC; Dimier-Poisson IH; Bout DT; Kasper LH
    J Immunol; 1997 Jun; 158(12):5883-9. PubMed ID: 9190941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
    Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
    J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.
    Gazzinelli R; Xu Y; Hieny S; Cheever A; Sher A
    J Immunol; 1992 Jul; 149(1):175-80. PubMed ID: 1351500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
    Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
    J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice.
    Khan IA; Ely KH; Kasper LH
    J Immunol; 1991 Nov; 147(10):3501-6. PubMed ID: 1940350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
    Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
    J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of mice lacking the common cytokine receptor gamma-chain (gamma(c)) reveals an unexpected role for CD4+ T lymphocytes in early IFN-gamma-dependent resistance to Toxoplasma gondii.
    Scharton-Kersten T; Nakajima H; Yap G; Sher A; Leonard WJ
    J Immunol; 1998 Mar; 160(6):2565-9. PubMed ID: 9510152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-gamma-independent IL-12.
    Bliss SK; Zhang Y; Denkers EY
    J Immunol; 1999 Aug; 163(4):2081-8. PubMed ID: 10438947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.
    Hunter CA; Bermudez L; Beernink H; Waegell W; Remington JS
    Eur J Immunol; 1995 Apr; 25(4):994-1000. PubMed ID: 7737303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation.
    Deckert-Schlüter M; Rang A; Weiner D; Huang S; Wiestler OD; Hof H; Schlüter D
    Lab Invest; 1996 Dec; 75(6):827-41. PubMed ID: 8973478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.